AU2003274004A1 - Lisinopril/lercanidipine combination therapy - Google Patents

Lisinopril/lercanidipine combination therapy

Info

Publication number
AU2003274004A1
AU2003274004A1 AU2003274004A AU2003274004A AU2003274004A1 AU 2003274004 A1 AU2003274004 A1 AU 2003274004A1 AU 2003274004 A AU2003274004 A AU 2003274004A AU 2003274004 A AU2003274004 A AU 2003274004A AU 2003274004 A1 AU2003274004 A1 AU 2003274004A1
Authority
AU
Australia
Prior art keywords
lercanidipine
lisinopril
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003274004A
Inventor
Amedeo Leonardi
Abraham Sartani
Giorgio Sironi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati Ireland Ltd
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20022594 external-priority patent/ITMI20022594A1/en
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of AU2003274004A1 publication Critical patent/AU2003274004A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003274004A 2002-10-16 2003-10-15 Lisinopril/lercanidipine combination therapy Abandoned AU2003274004A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41979002P 2002-10-16 2002-10-16
US60/419,790 2002-10-16
ITMI20022594 ITMI20022594A1 (en) 2002-12-06 2002-12-06 THERAPEUTIC COMBINATION FOR THE TREATMENT OF HYPERTENSION.
ITMI2002A002594 2002-12-06
PCT/EP2003/011389 WO2004035051A1 (en) 2002-10-16 2003-10-15 Lisinopril/lercanidipine combination therapy

Publications (1)

Publication Number Publication Date
AU2003274004A1 true AU2003274004A1 (en) 2004-05-04

Family

ID=32109309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003274004A Abandoned AU2003274004A1 (en) 2002-10-16 2003-10-15 Lisinopril/lercanidipine combination therapy

Country Status (4)

Country Link
EP (1) EP1553941A1 (en)
JP (1) JP2006504800A (en)
AU (1) AU2003274004A1 (en)
WO (1) WO2004035051A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
AR053023A1 (en) * 2005-02-25 2007-04-18 Recordati Ireland Ltd LERCANIDIPINE FREE BASE, METHODS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274480B (en) * 1995-05-12 1997-07-17 Recordati Chem Pharm IMPROVED PROCEDURE FOR THE PREPARATION OF LERCANIDIPINE HYDROCHLORIDE
US5912351A (en) * 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
GT199800126A (en) * 1997-08-29 2000-01-29 COMBINATION THERAPY.
WO2001015674A2 (en) * 1999-08-30 2001-03-08 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events

Also Published As

Publication number Publication date
JP2006504800A (en) 2006-02-09
WO2004035051A1 (en) 2004-04-29
EP1553941A1 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
AU2003224725A1 (en) Hiv therapeutic
AU2003281505A1 (en) Chair
AU2003279911A1 (en) Therapeutic formulations
AU2003235123A1 (en) Unit
AU2003283626A1 (en) Catheter
AUPS160602A0 (en) Therapeutic method
AU2003247005A1 (en) Therapy combination
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003215150A1 (en) Therapeutic compounds
AU2003282722A1 (en) Therapeutic compositions
AU2003244140A1 (en) Catheter
AU2003206471A1 (en) Dental wedge
AU2003274004A1 (en) Lisinopril/lercanidipine combination therapy
AU2003231937A1 (en) Therapeutic methods
AU2002953547A0 (en) Therapeutic combination
AU2002953515A0 (en) Therapeutic compounds - II
AU2003230338A1 (en) Chair
AUPS283402A0 (en) Combination therapy
AU2002100471A4 (en) Timber treatment
AU2003902516A0 (en) Therapeutic compositions - II
AU2003207599A1 (en) Therapeutic decorative object
AU2002100468A4 (en) Flexi-edger
AU2002100482A4 (en) Tail-gate-ezy
AU2002100508A4 (en) Photocard
AU2002100031A4 (en) earliPay

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase